v3.26.1
SCHEDULE OF DISAGGREGATED REVENUE (Details) - USD ($)
 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Product Information [Line Items]    
Total revenue, net $ 35,695,614 $ 33,117,624
Sale of Pharmaceutical Products and Medical Consultations [Member]    
Product Information [Line Items]    
Total revenue, net 32,908,881 30,027,373
Shipping and Handling [Member]    
Product Information [Line Items]    
Total revenue, net 2,485,908 3,090,251
Other Revenue [Member]    
Product Information [Line Items]    
Total revenue, net $ 300,825